5 Things Regeneron's CEO Said As The Biotech Stock Sank

Published: Sep 12, 2017

Regeneron (NASDAQ:REGN) CEO Leonard Schleifer was on the hot seat Monday at the Morgan Stanley healthcare conference. And the timing was either terrific or terrible, depending on your perspective. Regeneron stock opened more than 4% below its previous close, and things got worse during intraday trading.

Back to news